Progression and metastasis of lung cancer
暂无分享,去创建一个
[1] S. Courtneidge,et al. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.
[2] A. Silvani,et al. CXCL12, CXCR4 and CXCR7 expression in brain metastases , 2009, Cancer biology & therapy.
[3] M. Selman,et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. , 2010, American journal of respiratory and critical care medicine.
[4] Sung-Hoon Kim,et al. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. , 2014, Oncology reports.
[5] F. Lecanda,et al. PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. , 2011, Cancer research.
[6] Dong-Yeop Shin,et al. EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] R. Franco,et al. Inhibition of stromal CXCR4 impairs development of lung metastases , 2012, Cancer Immunology, Immunotherapy.
[8] N. Probst-Hensch,et al. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.
[9] V. Seshan,et al. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. , 2015, Cancer discovery.
[10] F. Klamt,et al. The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. , 2014, Histology and histopathology.
[11] Jing Wu,et al. In vivo RNAi screen identifies candidate signaling genes required for collective cell migration in Drosophila ovary , 2014, Science China Life Sciences.
[12] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[13] M. Wang,et al. The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis , 2012, PloS one.
[14] R. Jain,et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation , 2011, Proceedings of the National Academy of Sciences.
[15] W. Dougall,et al. RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] Liu Li,et al. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. , 2009, Cancer biotherapy & radiopharmaceuticals.
[17] Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas , 2012, Clinical & Experimental Metastasis.
[18] D. Harder,et al. Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo , 2013, PloS one.
[19] Wei Li,et al. Effect of hypoxia-inducible factor-1α on transcription of survivin in non-small cell lung cancer , 2009, Journal of experimental & clinical cancer research : CR.
[20] Xuetao Cao,et al. Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I1 , 2009, The Journal of Immunology.
[21] H. Sakurai,et al. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 , 2006, Clinical & Experimental Metastasis.
[22] Y. Miller,et al. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. , 2005, Lung cancer.
[23] A. Gemma,et al. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma. , 2014, International journal of oncology.
[24] B. Zhivotovsky,et al. Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation , 2012, Autophagy.
[25] C. Degott,et al. Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non‐mucinous tumours , 2004, Histopathology.
[26] C. Horak,et al. Metastasis gets site specific. , 2005, Cancer cell.
[27] Gaetano Rocco,et al. Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line , 2011, PloS one.
[28] M. Kris,et al. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.
[29] Xingbin Hu,et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. , 2010, Cancer Research.
[30] Ruth J. Muschel,et al. Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.
[31] J. Becker,et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth , 2002, Nature Network Boston.
[32] Na Li,et al. SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells , 2012, PloS one.
[33] Changli Wang,et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. , 2012, Biochimica et biophysica acta.
[34] Z. Liao,et al. SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non–Small-Cell Lung Cancer , 2012, PloS one.
[35] W. Xu,et al. Depletion of CD4+CD25high regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy , 2009, Cancer biology & therapy.
[36] F. Dehghani,et al. Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells , 2013, Journal of visualized experiments : JoVE.
[37] David Haussler,et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma , 2011, Proceedings of the National Academy of Sciences.
[38] H. Kijima,et al. Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization , 2011, Molecular medicine.
[39] B. Housset,et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[40] A. J. Clifford,et al. BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .
[41] Oliver T. Bruns,et al. Selectins Mediate Small Cell Lung Cancer Systemic Metastasis , 2014, PloS one.
[42] D. Nguyen,et al. EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. , 2013, Cancer research.
[43] P. Laurent-Puig,et al. TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma , 2012, PloS one.
[44] A. Friedl,et al. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion , 2011, Cell and Tissue Research.
[45] Y. Sher,et al. ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells , 2014, PloS one.
[46] Javier De Las Rivas,et al. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. , 2008, Cancer research.
[47] G. Prendergast,et al. IDO is a nodal pathogenic driver of lung cancer and metastasis development. , 2012, Cancer discovery.
[48] I. Wistuba,et al. RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner , 2014, Molecular oncology.
[49] E. Yamamoto,et al. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity , 2009, Head & neck.
[50] Xianghuo He,et al. Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. , 2013, Journal of proteome research.
[51] Lin Han,et al. SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. , 2013, International journal of clinical and experimental pathology.
[52] S. Israels,et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF , 2003, Oncogene.
[53] Wim Timens,et al. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. , 2009, Lung cancer.
[54] W. Fu,et al. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. , 2008, Carcinogenesis.
[55] H. Popper,et al. Sarcomatoid carcinomas of the lung—are these histogenetically heterogeneous tumors? , 2006, Virchows Archiv.
[56] T. Lyberg,et al. Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[57] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[58] Jun-ling Liu,et al. Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells , 2012, Journal of cellular biochemistry.
[59] F. Wang,et al. -216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma , 2013, Oncology letters.
[60] Zuozhang Yang,et al. Genome-Wide Identification of Bone Metastasis-Related MicroRNAs in Lung Adenocarcinoma by High-Throughput Sequencing , 2013, PloS one.
[61] D. Slamon,et al. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. , 2010, Lung cancer.
[62] S. Grossman,et al. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. , 2007, Cancer research.
[63] A. Whetton,et al. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. , 2014, Cancer treatment reviews.
[64] H. Aburatani,et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci , 2013, Nature Communications.
[65] H. Popper. Lung adenocarcinomas: comparison between mice and men. , 2015, Methods in molecular biology.
[66] W. Guo,et al. Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer , 2013, PloS one.
[67] K. Luzzi,et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.
[68] A. Varki,et al. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. , 2003, The Journal of clinical investigation.
[69] R. Mirimanoff,et al. CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. , 2008, Cancer research.
[70] E. Wang,et al. Hypoxia-induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells , 2009, Cancer biology & therapy.
[71] Tae Min Kim,et al. Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[72] I. Takanami,et al. Expression of Ets-1 Is Correlated with Urokinase-Type Plasminogen Activator and Poor Prognosis in Pulmonary Adenocarcinoma , 2001, Tumor Biology.
[73] E. Brambilla,et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival , 1999, The Journal of pathology.
[74] W. Dougall,et al. Mixed Metastatic Lung Cancer Lesions in Bone Are Inhibited by Noggin Overexpression and Rank:Fc Administration , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[75] N. Pećina-Šlaus,et al. Brain Metastases from Lung Cancer Show Increased Expression of DVL1, DVL3 and Beta-Catenin and Down-Regulation of E-Cadherin , 2014, International journal of molecular sciences.
[76] B. Ylstra,et al. Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion , 2009, Clinical Cancer Research.
[77] J. Hung,et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. , 2013, Biochimica et biophysica acta.
[78] W. Berger,et al. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer. , 2014, Lung cancer.
[79] M. Hung,et al. ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. , 2014, Cancer research.
[80] Ming Chen,et al. TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]. , 2009, Experimental and molecular pathology.
[81] E Helene Sage,et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. , 2003, Cancer research.
[82] Leo Kinarsky,et al. Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. , 2007, Omics : a journal of integrative biology.
[83] Myung-Soo Kang,et al. Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma , 2013, Clinical Cancer Research.
[84] I. Pass,et al. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. , 2008, European journal of cell biology.
[85] J. Tímár,et al. Protein expression differences between lung adenocarcinoma and squamous cell carcinoma with brain metastasis. , 2014, Anticancer research.
[86] D. Spector,et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.
[87] R. Xiang,et al. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis , 2008, Immunological reviews.
[88] C. Rudin,et al. Notch Signaling Contributes to Lung Cancer Clonogenic Capacity In Vitro but May Be Circumvented in Tumorigenesis In Vivo , 2011, Molecular Cancer Research.
[89] M. Meyerson,et al. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer , 2011, Modern Pathology.
[90] Mingyong Han,et al. Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model , 2014, Cancer biology & therapy.
[91] Fu-Tsai Chung,et al. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. , 2012, American journal of respiratory and critical care medicine.
[92] R. Muschel,et al. VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. , 2013, Blood.
[93] G. Pelosi,et al. Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.
[94] Z. Liao,et al. Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer , 2013, Clinical Cancer Research.
[95] S. Mader,et al. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis , 2000, Oncogene.
[96] M. Noguchi,et al. The development and progression of adenocarcinoma of the lung. , 1995, Cancer treatment and research.
[97] C. Panje,et al. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC) , 2015, Clinical & Experimental Metastasis.
[98] E. Smit,et al. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? , 2014, Lung cancer.
[99] A. Bertuzzi,et al. Cell kinetics in a tumour cord. , 2000, Journal of theoretical biology.
[100] P. Sykacek,et al. A dual role for autophagy in a murine model of lung cancer , 2014, Nature Communications.
[101] J. Snyder,et al. Development of a Unique Small Molecule Modulator of CXCR4 , 2012, PloS one.
[102] B. Gao,et al. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines , 2006, Cancer biology & therapy.
[103] H. Popper,et al. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[104] Chung-Wu Lin,et al. CHC promotes tumor growth and angiogenesis through regulation of HIF-1α and VEGF signaling. , 2012, Cancer letters.
[105] M. Noguchi,et al. Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue , 2004, Cancer science.
[106] Lei Zhao,et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. , 2012, Blood.
[107] F. Lecanda,et al. Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis , 2012, Clinical Cancer Research.
[108] M. Cao,et al. IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo , 2010, Cancer Immunology, Immunotherapy.
[109] E. Puré,et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. , 2009, The Journal of clinical investigation.
[110] K. Alitalo,et al. Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis , 2012, Journal of the National Cancer Institute.
[111] S. Liang,et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway , 2010, Oncogene.
[112] J. Wan,et al. The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells , 2009, Journal of experimental & clinical cancer research : CR.
[113] H. Satoh,et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. , 2015, Molecular and clinical oncology.
[114] Zhou Wang,et al. High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer , 2014, Oncology letters.
[115] B. Son,et al. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model , 2012, Journal of Neuro-Oncology.
[116] S. Hoersch,et al. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. , 2013, Genes & development.
[117] W. Sessa,et al. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. , 2007, Cancer research.
[118] Yan Xu,et al. The Ubiquitin–CXCR4 Axis Plays an Important Role in Acute Lung Infection–Enhanced Lung Tumor Metastasis , 2013, Clinical Cancer Research.
[119] Herb Chen,et al. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. , 2007, The oncologist.
[120] I. Holen,et al. Targeting RANKL in metastasis , 2014, BoneKEy reports.
[121] J. Siegfried,et al. Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.
[122] I. Bechmann,et al. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way , 2010, Glia.
[123] Ling Wei,et al. Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration. , 2012, Cancer biotherapy & radiopharmaceuticals.
[124] K. Willecke,et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. , 2008, BMC medicine.
[125] David E. Misek,et al. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. , 2004, Clinical lung cancer.
[126] E. Puré,et al. Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. , 2013, Cancer research.
[127] S. Eccles,et al. Phosphoinositide 3-Kinase Signalling Pathways in Tumor Progression, Invasion and Angiogenesis , 2004, Tumori.